Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae

scientific article published on 26 January 2011

Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJANTIMICAG.2010.11.028
P698PubMed publication ID21276715
P5875ResearchGate publication ID49794069

P50authorDavid M. LivermoreQ100272320
P2093author name stringMarina Warner
Shazad Mushtaq
Tue Nguyen
P433issue5
P304page(s)405-409
P577publication date2011-01-26
P1433published inInternational Journal of Antimicrobial AgentsQ15724616
P1476titleStrategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae
P478volume37

Reverse relations

cites work (P2860)
Q36660493CTX-M-55-type extended-spectrum β-lactamase-producing Shigella sonnei isolated from a Korean patient who had travelled to China
Q38115356Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.
Q53697061Defining substrate specificity in the CTX-M family: the role of Asp240 in ceftazidime hydrolysis.
Q38143651Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria
Q34501014Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China
Q38832723Role of old antimicrobial agents in the management of urinary tract infection

Search more.